The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment-Reference-Cited by-同舟云学术

The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment

Published:2010-06 Issue: Volume:38 Page:S4-S13
ISSN:0740-5472
Container-title:Journal of Substance Abuse Treatment
language:en
Short-container-title:Journal of Substance Abuse Treatment

Author:

Tai Betty,Straus Michele M.,Liu David,Sparenborg Steven,Jackson Ron,McCarty Dennis

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health

Reference66 articles.

1. Promoting Awareness of Motivational Incentives. Addiction Technology Transfer Center Network:;Albright,2006

2. Bringing buprenorphine–naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience;Amass;American Journal on Addictions,2004

3. Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics;Ball;Journal of Consulting and Clinical Psychology,2007

4. Effects of adding behavioral treatment to opioid detoxification with buprenorphine;Bickel;Journal of Consulting and Clinical Psychology,1997

5. Using buprenorphine short-term taper to facilitate early treatment engagement;Brigham;Journal of Substance Abuse Treatment,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Family history of substance problems among African Americans: Associations with drug use, drug use disorder, and prescription drug misuse;Journal of Ethnicity in Substance Abuse;2024-03-26

2. Experimental designs for addiction research;Substance Use and Addiction Research;2023

3. Use of Evidence-Based Technology to Assist the Behavioral Health Workforce;Journal of Addictions Nursing;2021-07

4. Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations;Contemporary Clinical Trials;2020-06

5. Validation of Addiction Severity Index (ASI) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials;Journal of Dual Diagnosis;2020-04-07